SEC Form 4 · accession 0001103780-17-000005
Lexaria Bioscience Corp. · LXRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Allan Horst Spissinger
Officer — CFO
Period of report
Jan 9, 2017
Accepted (ET)
Dec 1, 2017 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001348362
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Dec 1, 2017 | A | 41,666 | $0.82 | A | 69,166 | D | |
| Common Shares | holding | — | — | — | 27,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $0.83 | Dec 1, 2017 | A | 200,000 | A | Dec 1, 2017 | Dec 1, 2022 | Common Shares | 200,000 | 400,000 | D |
| Stock Options | $0.37 | holding | — | — | — | Jun 1, 2017 | Jun 1, 2022 | Common Shares | 200,000 | 200,000 | D |